Showing results (101-110 of 192) with videos related to

Sort By:
Pageof 20
Zhongguo Fei AI Za Zhi = Chinese Journal of Lung Cancer|March 22, 2013
[Efficacy of icotinib for advanced non-small cell lung cancer patients with EGFR status identified]Zhengbo Song, Xinmin Yu, Jufen Cai, et al.
Zhonghua Zhong Liu Za Zhi [Chinese Journal of Oncology]|January 28, 2016
[Efficacy of crizotinib for 28 cases of advanced ALK-positive non-small cell lung cancer]Wenxian Wang, Zhengbo Song, Xinmin Yu, et al.
Translational Cancer Research|April 10, 2023
Efficacy and safety of immune checkpoint inhibitors (ICIs) combined with antiangiogenic therapy for thymic epithelial tumors (TETs): a retrospective studyJing Xiang, Jinfei Si, Yue Hao, et al.
International Journal of Clinical Pharmacy|April 26, 2025
Post-marketing safety of pralsetinib: a real-world disproportionality analysis based on the FDA adverse event reporting system databaseZheng Shi, Keda Shao, Ke Wang, et al.
Journal of Pharmaceutical and Biomedical Analysis|December 30, 2019
Metabolic and lipidomic characterization of malignant pleural effusion in human lung cancerZhiyi Yang, Zhengbo Song, Zhongjian Chen, et al.
BMC Cancer|May 23, 2022
Efficacy and safety of maintenance immune checkpoint inhibitors with or without pemetrexed in advanced non-squamous non-small cell lung cancer: a retrospective studyXiaodong Gu, Zhiyong Shi, Lan Shao, et al.
Zhongguo Fei AI Za Zhi = Chinese Journal of Lung Cancer|December 19, 2013
[Relationship between BIM gene polymorphism and therapeutic efficacy in the retreatment of advanced non-small cell lung cancer with tyrosine kinase inhibitor]Lei Zheng, Baochai Lin, Zhengbo Song, et al.
BMC Cancer|September 17, 2021
Pyrotinib combined with thalidomide in advanced non-small-cell lung cancer patients harboring HER2 exon 20 insertions (PRIDE): protocol of an open-label, single-arm phase II trialXinghao Ai, Zhengbo Song, Hong Jian, et al.
Analytica Chimica Acta|July 18, 2020
Large-scale targeted metabolomics method for metabolite profiling of human samplesGuodong Cao, Zhengbo Song, Yanjun Hong, et al.
Chinese Medical Journal|January 21, 2014
Efficacy and safety of icotinib in Chinese patients with advanced non-small cell lung cancer after failure of chemotherapyLan Shao, Beibei Zhang, Chunxiao He, et al.
Pageof 20